Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Physician Marketing 2025

Pharma Doctor Outreach Rises as D2C Drug Ads Face Scrutiny

Download
Share
About This Report
With tighter rules looming for D2C drug ads, pharma must strengthen its marketing efforts to healthcare professionals (HCPs). Delivering data-driven outreach and credible clinical content on digital channels that physicians frequent will be key to sustaining drug awareness and prescriptions amid declining HCP access.
Table of Contents

Tougher D2C ad regulations will push pharma to rely more on doctors for patient drug education and prescription growth. This report examines how pharma marketers can more effectively use digital tools and channels to create credible engagement strategies that offset decreased consumer exposure.

Key Question: How are physician preferences for pharma content consumption evolving, and how can marketers use digital tools to better engage them?

Key Stat: Healthcare and pharma marketers will spend $2.11 billion on B2B digital ad spending in 2025, up 10.7% YoY, reaching $2.54 billion by 2027.

Here’s what’s in the full report

1file

Exportable files for easy reading, analysis and sharing.

7charts

Reliable data in simple displays for presentations and quick decision making.

4expert perspectives

Insights from industry and company leaders.

    Table of Contents

    1. Executive Summary
    2. With D2C drug advertising in flux, pharma must strengthen HCP outreach
    3. Drugmakers must adapt to HCPs’ online behaviors and preferred channels for receiving medical information
    1. Hyperefficient, digital-first strategies counteract declining HCP access
    2. Recommendations for marketers
    3. EMARKETER Interviews
    1. Sources
    2. Media Gallery

    Interviewed for This Report

    Ian Essling
    CMI Media Group
    Director, Audience Intelligence
    Interviewed September 30, 2025
    Manoj Hariharaputhiran
    ZoomRx
    Project Manager
    Interviewed September 15, 2025
    Jay Schwartz
    Indegene
    Vice President, Customer Engagement Omnichannel
    Interviewed October 3, 2025
    Sarah Tomalavage
    CMI Media Group
    Group Senior Vice President, Engagement Strategy
    Interviewed September 30, 2025

    authors

    Rajiv Leventhal

    Contributors

    Beth Snyder Bulik
    Eleni Digalaki
    Nikolai Dineros
    Donte Gibson
    Senior Charts Editor
    Jennifer Pearson
    VP, Research
    Heather Sprung
    Senior Editor
    Emman Velasco
    Chart Editor
    Paul Verna
    VP, Content
    Already have a subscription?Sign In

    Access All Charts and Data

    Gain access to reliable data presented in clear and intelligible displays for quick understanding and decision making on the most important topics related to your industry

    Become a Client
    Unlock Unlimited Insights with PRO+